Delivery Order W81K0219D0011-W81K0223F0060
Award Date
6/1/23
Potential Completion Date
9/28/23
Potential Value
$8.9K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Revvity Omics Inc.
Ultimate Awardee
Revvity Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for newborn screening testing services provided by Revvity Omics Inc., doing business as Perkinelmer Genetics, to the Defense Health Agency (DHA) for the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The contract is a firm fixed price delivery order under a larger indefinite delivery, indefinite quantity (IDIQ) contract awarded to Perkinelmer Genetics in 2019 by the DHA to provide newborn screening for Army medical facilities in Korea. The...
The Department of the Army Medical Command awarded a $45,092.88 firm fixed price delivery order to Perkinelmer Genetics, Inc. of Pittsburgh, Pennsylvania for newborn screening testing services in support of Brian D. Allgood Army Community Hospital and the 121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide newborn screening to be performed at its laboratory in Pittsburgh on samples collected at the Army medical treatment facilities. The testing...
This firm fixed price delivery order for $40,945.50 was awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea. The order is for the base period of September 29, 2024 through September 28, 2025. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., is a for-profit organization that specializes in medical imaging and genetic...
The Department of the Army Medical Command has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to PerkinElmer Genetics, Inc., a for-profit organization, to provide newborn screening test kits. The contract, valued at $148,000.00, requires PerkinElmer Genetics to conduct testing for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. The services will support military hospitals and treatment...
This contract was awarded by the Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, and has a potential value of $150,000.00. The services under this contract include testing newborns for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. These...
The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn metabolic screening services. The contract, valued at $56,927.50, has an ultimate completion date of February 28, 2027. The contract was awarded without a small business set-aside designation. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in providing comprehensive newborn screening testing services to federal government...
This contract was awarded by the U.S. Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit medical services provider, to conduct newborn screening testing. The contract has a firm fixed price of $148,000.00 and a completion date of September 30, 2020. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in newborn and genetic screening services to support military hospitals and treatment facilities in the U.S. and overseas. This...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services. The contract has a ceiling value of $371,000.00 and a period of performance from October 1, 2021 through September 30, 2024. Perkinelmer Genetics will provide screening of newborns for inherited metabolic disorders and other conditions, as recommended by the American College of Medical Genetics, for military...
This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...